Literature DB >> 31049341

Occupational Retronychia: A Report of a Case in a UPS Employee.

Nicole Nagrani1, David E Castillo1, Hind Al-Mohanna1, Antonella Tosti1.   

Abstract

Retronychia is a frequently misdiagnosed nail disorder characterized by proximal ingrowth of the nail into the proximal nail plate. Often presenting with chronic paronychia, retronychia is commonly misdiagnosed and treated ineffectively with antimicrobials. The main cause is repeated micro-trauma to the affected nail, therefore a thorough history of exposures and insults to the toenail is crucial in identifying the cause of this nail abnormality. Herein, we describe a case of a UPS employee who presented with a painful nail after dropping a package on her foot that was unresponsive to medical treatment for 2 years. This case highlights the importance of taking a thorough history and physical examination for diagnosing retronychia.

Entities:  

Keywords:  Nail disorder; Occupational nail disorders; Occupational retronychia; Retronychia

Year:  2019        PMID: 31049341      PMCID: PMC6489046          DOI: 10.1159/000494729

Source DB:  PubMed          Journal:  Skin Appendage Disord        ISSN: 2296-9160


  4 in total

1.  Retronychia: diagnosis and treatment.

Authors:  Marc Baumgartner; Eckart Haneke
Journal:  Dermatol Surg       Date:  2010-08-16       Impact factor: 3.398

Review 2.  "Retronychia--clinical and pathophysiological aspects".

Authors:  F Ventura; O Correia; A F Duarte; A M Barros; E Haneke
Journal:  J Eur Acad Dermatol Venereol       Date:  2015-10-05       Impact factor: 6.166

3.  Retronychia: proximal ingrowing of the nail plate.

Authors:  David A de Berker; Bertrand Richert; Edith Duhard; Bianca Maria Piraccini; Josette André; Robert Baran
Journal:  J Am Acad Dermatol       Date:  2008-03-28       Impact factor: 11.527

4.  Risk factors, clinical variants and therapeutic outcome of retronychia: a retrospective study of 18 patients.

Authors:  Emilie Gerard; Christos Prevezas; Marie-Sylvie Doutre; Marie Beylot-Barry; Olivier Cogrel
Journal:  Eur J Dermatol       Date:  2016-08-01       Impact factor: 3.328

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.